nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—SLC22A7—Rifampicin—leprosy	0.386	0.477	CbGbCtD
Enalapril—SLCO1A2—Rifampicin—leprosy	0.271	0.334	CbGbCtD
Enalapril—ABCB1—Rifampicin—leprosy	0.0732	0.0903	CbGbCtD
Enalapril—CYP3A4—Rifampicin—leprosy	0.0438	0.0541	CbGbCtD
Enalapril—CYP3A4—Dapsone—leprosy	0.0362	0.0447	CbGbCtD
Enalapril—Pulmonary eosinophilia—Dapsone—leprosy	0.0156	0.0938	CcSEcCtD
Enalapril—Pain in arm—Thalidomide—leprosy	0.00886	0.0534	CcSEcCtD
Enalapril—Pyuria—Thalidomide—leprosy	0.00416	0.0251	CcSEcCtD
Enalapril—ACE—hindlimb—leprosy	0.00374	0.155	CbGeAlD
Enalapril—ACE—arm—leprosy	0.00357	0.148	CbGeAlD
Enalapril—Dysaesthesia—Thalidomide—leprosy	0.00336	0.0203	CcSEcCtD
Enalapril—Proteinuria—Dapsone—leprosy	0.00323	0.0195	CcSEcCtD
Enalapril—ACE—appendage—leprosy	0.00321	0.133	CbGeAlD
Enalapril—Protein urine present—Dapsone—leprosy	0.00319	0.0192	CcSEcCtD
Enalapril—ACE—peripheral nervous system—leprosy	0.00292	0.121	CbGeAlD
Enalapril—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.0025	0.0151	CcSEcCtD
Enalapril—Toothache—Thalidomide—leprosy	0.00239	0.0144	CcSEcCtD
Enalapril—Serum creatinine increased—Thalidomide—leprosy	0.00236	0.0143	CcSEcCtD
Enalapril—ACE—nerve—leprosy	0.00227	0.094	CbGeAlD
Enalapril—Nasopharyngitis—Dapsone—leprosy	0.00184	0.0111	CcSEcCtD
Enalapril—ACE—blood vessel—leprosy	0.00179	0.0739	CbGeAlD
Enalapril—Influenza—Dapsone—leprosy	0.00178	0.0107	CcSEcCtD
Enalapril—Pancreatitis—Dapsone—leprosy	0.00175	0.0105	CcSEcCtD
Enalapril—Proteinuria—Thalidomide—leprosy	0.00166	0.00998	CcSEcCtD
Enalapril—Jaundice cholestatic—Thalidomide—leprosy	0.00166	0.00998	CcSEcCtD
Enalapril—Protein urine present—Thalidomide—leprosy	0.00163	0.00984	CcSEcCtD
Enalapril—Photosensitivity reaction—Dapsone—leprosy	0.00163	0.00981	CcSEcCtD
Enalapril—Oliguria—Thalidomide—leprosy	0.00158	0.00952	CcSEcCtD
Enalapril—Drug interaction—Thalidomide—leprosy	0.00157	0.00945	CcSEcCtD
Enalapril—Neuropathy peripheral—Dapsone—leprosy	0.00156	0.00939	CcSEcCtD
Enalapril—Leukocytosis—Thalidomide—leprosy	0.00155	0.00933	CcSEcCtD
Enalapril—Hearing impaired—Thalidomide—leprosy	0.00153	0.00921	CcSEcCtD
Enalapril—Sinusitis—Dapsone—leprosy	0.00149	0.00899	CcSEcCtD
Enalapril—Neck pain—Thalidomide—leprosy	0.00147	0.00888	CcSEcCtD
Enalapril—Pulmonary embolism—Thalidomide—leprosy	0.00145	0.00877	CcSEcCtD
Enalapril—Hyperkalaemia—Thalidomide—leprosy	0.00143	0.00862	CcSEcCtD
Enalapril—Pharyngitis—Dapsone—leprosy	0.00142	0.00854	CcSEcCtD
Enalapril—Blood urea increased—Thalidomide—leprosy	0.00137	0.00828	CcSEcCtD
Enalapril—Dry eye—Thalidomide—leprosy	0.00134	0.0081	CcSEcCtD
Enalapril—Tinnitus—Dapsone—leprosy	0.00133	0.00802	CcSEcCtD
Enalapril—Gynaecomastia—Thalidomide—leprosy	0.0013	0.00785	CcSEcCtD
Enalapril—Pulmonary oedema—Thalidomide—leprosy	0.00129	0.00781	CcSEcCtD
Enalapril—Erythema—Dapsone—leprosy	0.00124	0.00749	CcSEcCtD
Enalapril—Photosensitivity—Thalidomide—leprosy	0.0012	0.00725	CcSEcCtD
Enalapril—Deafness—Thalidomide—leprosy	0.00118	0.00712	CcSEcCtD
Enalapril—Vision blurred—Dapsone—leprosy	0.00117	0.00706	CcSEcCtD
Enalapril—Libido decreased—Thalidomide—leprosy	0.00114	0.00687	CcSEcCtD
Enalapril—Dermatitis exfoliative—Thalidomide—leprosy	0.00112	0.00675	CcSEcCtD
Enalapril—Vertigo—Dapsone—leprosy	0.00112	0.00673	CcSEcCtD
Enalapril—Visual disturbance—Thalidomide—leprosy	0.00111	0.00672	CcSEcCtD
Enalapril—Atrial fibrillation—Thalidomide—leprosy	0.00111	0.00672	CcSEcCtD
Enalapril—Arthritis—Thalidomide—leprosy	0.00109	0.00655	CcSEcCtD
Enalapril—Cough—Dapsone—leprosy	0.00108	0.00654	CcSEcCtD
Enalapril—Hypoglycaemia—Thalidomide—leprosy	0.00108	0.00652	CcSEcCtD
Enalapril—Cerebrovascular accident—Thalidomide—leprosy	0.00108	0.0065	CcSEcCtD
Enalapril—Hyponatraemia—Thalidomide—leprosy	0.00106	0.00639	CcSEcCtD
Enalapril—Pain in extremity—Thalidomide—leprosy	0.00106	0.00637	CcSEcCtD
Enalapril—Disturbance in sexual arousal—Thalidomide—leprosy	0.00105	0.00632	CcSEcCtD
Enalapril—Face oedema—Thalidomide—leprosy	0.00102	0.00615	CcSEcCtD
Enalapril—Cardiac arrest—Thalidomide—leprosy	0.001	0.00605	CcSEcCtD
Enalapril—Ataxia—Thalidomide—leprosy	0.000993	0.00599	CcSEcCtD
Enalapril—Tachycardia—Dapsone—leprosy	0.000989	0.00597	CcSEcCtD
Enalapril—Blood creatinine increased—Thalidomide—leprosy	0.000989	0.00596	CcSEcCtD
Enalapril—Dry skin—Thalidomide—leprosy	0.000968	0.00584	CcSEcCtD
Enalapril—Orthostatic hypotension—Thalidomide—leprosy	0.000964	0.00581	CcSEcCtD
Enalapril—SLC22A8—eye—leprosy	0.000954	0.0394	CbGeAlD
Enalapril—Cramp muscle—Thalidomide—leprosy	0.000951	0.00573	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000951	0.00573	CcSEcCtD
Enalapril—ACE—eye—leprosy	0.000951	0.0393	CbGeAlD
Enalapril—Alanine aminotransferase increased—Thalidomide—leprosy	0.000931	0.00561	CcSEcCtD
Enalapril—Insomnia—Dapsone—leprosy	0.000917	0.00553	CcSEcCtD
Enalapril—Dysphagia—Thalidomide—leprosy	0.000913	0.0055	CcSEcCtD
Enalapril—Influenza—Thalidomide—leprosy	0.000913	0.0055	CcSEcCtD
Enalapril—SLC22A7—testis—leprosy	0.000905	0.0374	CbGeAlD
Enalapril—Eosinophilia—Thalidomide—leprosy	0.000904	0.00545	CcSEcCtD
Enalapril—Bronchospasm—Thalidomide—leprosy	0.000898	0.00541	CcSEcCtD
Enalapril—Pancreatitis—Thalidomide—leprosy	0.000895	0.00539	CcSEcCtD
Enalapril—Angina pectoris—Thalidomide—leprosy	0.000889	0.00536	CcSEcCtD
Enalapril—Bronchitis—Thalidomide—leprosy	0.000878	0.00529	CcSEcCtD
Enalapril—Pancytopenia—Thalidomide—leprosy	0.000867	0.00523	CcSEcCtD
Enalapril—Neutropenia—Thalidomide—leprosy	0.000853	0.00515	CcSEcCtD
Enalapril—Upper respiratory tract infection—Thalidomide—leprosy	0.000848	0.00511	CcSEcCtD
Enalapril—Pollakiuria—Thalidomide—leprosy	0.000843	0.00508	CcSEcCtD
Enalapril—Erectile dysfunction—Thalidomide—leprosy	0.000841	0.00507	CcSEcCtD
Enalapril—Photosensitivity reaction—Thalidomide—leprosy	0.000833	0.00502	CcSEcCtD
Enalapril—Gastrointestinal pain—Dapsone—leprosy	0.000829	0.005	CcSEcCtD
Enalapril—Hyperglycaemia—Thalidomide—leprosy	0.000823	0.00496	CcSEcCtD
Enalapril—Pneumonia—Thalidomide—leprosy	0.000818	0.00493	CcSEcCtD
Enalapril—Depression—Thalidomide—leprosy	0.000811	0.00489	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000807	0.00486	CcSEcCtD
Enalapril—Acute coronary syndrome—Thalidomide—leprosy	0.000802	0.00484	CcSEcCtD
Enalapril—Body temperature increased—Dapsone—leprosy	0.000801	0.00483	CcSEcCtD
Enalapril—Abdominal pain—Dapsone—leprosy	0.000801	0.00483	CcSEcCtD
Enalapril—Renal failure—Thalidomide—leprosy	0.0008	0.00482	CcSEcCtD
Enalapril—Myocardial infarction—Thalidomide—leprosy	0.000798	0.00481	CcSEcCtD
Enalapril—Neuropathy peripheral—Thalidomide—leprosy	0.000798	0.00481	CcSEcCtD
Enalapril—Stomatitis—Thalidomide—leprosy	0.000793	0.00478	CcSEcCtD
Enalapril—Conjunctivitis—Thalidomide—leprosy	0.000791	0.00477	CcSEcCtD
Enalapril—Epistaxis—Thalidomide—leprosy	0.000767	0.00463	CcSEcCtD
Enalapril—Sinusitis—Thalidomide—leprosy	0.000763	0.0046	CcSEcCtD
Enalapril—Agranulocytosis—Thalidomide—leprosy	0.000759	0.00458	CcSEcCtD
Enalapril—Bradycardia—Thalidomide—leprosy	0.000744	0.00448	CcSEcCtD
Enalapril—Hepatitis—Thalidomide—leprosy	0.00073	0.0044	CcSEcCtD
Enalapril—Pharyngitis—Thalidomide—leprosy	0.000725	0.00437	CcSEcCtD
Enalapril—Visual impairment—Thalidomide—leprosy	0.000704	0.00424	CcSEcCtD
Enalapril—Erythema multiforme—Thalidomide—leprosy	0.000691	0.00416	CcSEcCtD
Enalapril—Tinnitus—Thalidomide—leprosy	0.000681	0.00411	CcSEcCtD
Enalapril—Arrhythmia—Thalidomide—leprosy	0.000653	0.00393	CcSEcCtD
Enalapril—Alopecia—Thalidomide—leprosy	0.000645	0.00389	CcSEcCtD
Enalapril—Vomiting—Dapsone—leprosy	0.000645	0.00389	CcSEcCtD
Enalapril—Headache—Dapsone—leprosy	0.000635	0.00383	CcSEcCtD
Enalapril—ABCB1—blood vessel—leprosy	0.000629	0.026	CbGeAlD
Enalapril—Flatulence—Thalidomide—leprosy	0.000627	0.00378	CcSEcCtD
Enalapril—Tension—Thalidomide—leprosy	0.000624	0.00376	CcSEcCtD
Enalapril—Dysgeusia—Thalidomide—leprosy	0.000623	0.00375	CcSEcCtD
Enalapril—Nervousness—Thalidomide—leprosy	0.000618	0.00372	CcSEcCtD
Enalapril—Back pain—Thalidomide—leprosy	0.000615	0.00371	CcSEcCtD
Enalapril—Muscle spasms—Thalidomide—leprosy	0.000611	0.00369	CcSEcCtD
Enalapril—Nausea—Dapsone—leprosy	0.000602	0.00363	CcSEcCtD
Enalapril—Vision blurred—Thalidomide—leprosy	0.000599	0.00361	CcSEcCtD
Enalapril—Tremor—Thalidomide—leprosy	0.000596	0.00359	CcSEcCtD
Enalapril—Anaemia—Thalidomide—leprosy	0.000588	0.00354	CcSEcCtD
Enalapril—Agitation—Thalidomide—leprosy	0.000584	0.00352	CcSEcCtD
Enalapril—Angioedema—Thalidomide—leprosy	0.000581	0.0035	CcSEcCtD
Enalapril—Vertigo—Thalidomide—leprosy	0.000571	0.00344	CcSEcCtD
Enalapril—Syncope—Thalidomide—leprosy	0.00057	0.00344	CcSEcCtD
Enalapril—Leukopenia—Thalidomide—leprosy	0.000569	0.00343	CcSEcCtD
Enalapril—Palpitations—Thalidomide—leprosy	0.000562	0.00339	CcSEcCtD
Enalapril—Loss of consciousness—Thalidomide—leprosy	0.000559	0.00337	CcSEcCtD
Enalapril—Cough—Thalidomide—leprosy	0.000555	0.00335	CcSEcCtD
Enalapril—SLCO1A2—testis—leprosy	0.000548	0.0226	CbGeAlD
Enalapril—Chest pain—Thalidomide—leprosy	0.000541	0.00326	CcSEcCtD
Enalapril—Myalgia—Thalidomide—leprosy	0.000541	0.00326	CcSEcCtD
Enalapril—Arthralgia—Thalidomide—leprosy	0.000541	0.00326	CcSEcCtD
Enalapril—SLCO1A2—nervous system—leprosy	0.000538	0.0222	CbGeAlD
Enalapril—Discomfort—Thalidomide—leprosy	0.000535	0.00322	CcSEcCtD
Enalapril—Dry mouth—Thalidomide—leprosy	0.000529	0.00319	CcSEcCtD
Enalapril—Confusional state—Thalidomide—leprosy	0.000523	0.00316	CcSEcCtD
Enalapril—ACE—testis—leprosy	0.000521	0.0216	CbGeAlD
Enalapril—Oedema—Thalidomide—leprosy	0.000519	0.00313	CcSEcCtD
Enalapril—SLC22A8—nervous system—leprosy	0.000513	0.0212	CbGeAlD
Enalapril—ACE—nervous system—leprosy	0.000512	0.0212	CbGeAlD
Enalapril—Shock—Thalidomide—leprosy	0.000511	0.00308	CcSEcCtD
Enalapril—Thrombocytopenia—Thalidomide—leprosy	0.000508	0.00306	CcSEcCtD
Enalapril—Tachycardia—Thalidomide—leprosy	0.000506	0.00305	CcSEcCtD
Enalapril—Hyperhidrosis—Thalidomide—leprosy	0.000502	0.00302	CcSEcCtD
Enalapril—Anorexia—Thalidomide—leprosy	0.000495	0.00298	CcSEcCtD
Enalapril—Hypotension—Thalidomide—leprosy	0.000485	0.00292	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Thalidomide—leprosy	0.000473	0.00285	CcSEcCtD
Enalapril—Insomnia—Thalidomide—leprosy	0.000469	0.00283	CcSEcCtD
Enalapril—Paraesthesia—Thalidomide—leprosy	0.000466	0.00281	CcSEcCtD
Enalapril—Dyspnoea—Thalidomide—leprosy	0.000463	0.00279	CcSEcCtD
Enalapril—Somnolence—Thalidomide—leprosy	0.000461	0.00278	CcSEcCtD
Enalapril—Dyspepsia—Thalidomide—leprosy	0.000457	0.00275	CcSEcCtD
Enalapril—Decreased appetite—Thalidomide—leprosy	0.000451	0.00272	CcSEcCtD
Enalapril—Fatigue—Thalidomide—leprosy	0.000447	0.0027	CcSEcCtD
Enalapril—Constipation—Thalidomide—leprosy	0.000444	0.00268	CcSEcCtD
Enalapril—Feeling abnormal—Thalidomide—leprosy	0.000428	0.00258	CcSEcCtD
Enalapril—Gastrointestinal pain—Thalidomide—leprosy	0.000424	0.00256	CcSEcCtD
Enalapril—Urticaria—Thalidomide—leprosy	0.000412	0.00249	CcSEcCtD
Enalapril—Body temperature increased—Thalidomide—leprosy	0.00041	0.00247	CcSEcCtD
Enalapril—Abdominal pain—Thalidomide—leprosy	0.00041	0.00247	CcSEcCtD
Enalapril—Hypersensitivity—Thalidomide—leprosy	0.000382	0.00231	CcSEcCtD
Enalapril—Asthenia—Thalidomide—leprosy	0.000372	0.00224	CcSEcCtD
Enalapril—Pruritus—Thalidomide—leprosy	0.000367	0.00221	CcSEcCtD
Enalapril—Diarrhoea—Thalidomide—leprosy	0.000355	0.00214	CcSEcCtD
Enalapril—Dizziness—Thalidomide—leprosy	0.000343	0.00207	CcSEcCtD
Enalapril—Vomiting—Thalidomide—leprosy	0.00033	0.00199	CcSEcCtD
Enalapril—Rash—Thalidomide—leprosy	0.000327	0.00197	CcSEcCtD
Enalapril—Dermatitis—Thalidomide—leprosy	0.000327	0.00197	CcSEcCtD
Enalapril—Headache—Thalidomide—leprosy	0.000325	0.00196	CcSEcCtD
Enalapril—Nausea—Thalidomide—leprosy	0.000308	0.00186	CcSEcCtD
Enalapril—CYP3A4—nervous system—leprosy	0.000254	0.0105	CbGeAlD
Enalapril—ABCB1—testis—leprosy	0.000184	0.00759	CbGeAlD
Enalapril—ABCB1—nervous system—leprosy	0.00018	0.00745	CbGeAlD
